↧
Tekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing...
VANCOUVER, British Columbia -- Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference therapeutics, announced today that the United States Patent & Trademark Office has...
View ArticleAlnylam receives U.S. patent allowance for LNP platform
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for patent application number...
View Article